Back to search

Georgia Institute of Technology

Development of Intravaginal mRNA-Encoded Antibodies for HIV Prevention and Non-Hormonal Contraception

Abstract

dc:description.abstract

Many women face risks of HIV transmission and unintended pregnancies. Although effective prevention options exist, their real-world use is often limited by systemic side effects, adherence burdens, and limited user-controlled autonomy. Consequently, these barriers lead to inconsistent use and reduced effectiveness, underscoring a critical need for effective, safe, and accessible prevention strategies. To address these unmet needs, we present an mRNA-based multipurpose prevention technology (MPT) that uses the vaginal mucosa as an in situ bioreactor. This approach enables local expression of mRNA-encoded antibodies directly at the portal of viral entry and fertilization, reducing manufacturing complexity and high costs associated with recombinant protein prophylactics. We first focused on rationally designing mRNA constructs to drive the expression of broadly neutralizing antibodies (bnAbs) with enhanced breadth and potency against HIV in the mucosal environment. Translating these findings to a clinically relevant non-human primate model, we demonstrated that this platform confers robust protective efficacy against repeated high-dose SHIV challenges, while maintaining a favorable safety profile. Beyond viral prophylaxis, we expanded the platform’s utility to include non-hormonal contraception. We successfully engineered a dual-function formulation that co-expresses anti-HIV and anti-sperm antibodies, providing proof-of-concept for a single-dose strategy capable of simultaneous virus neutralization and sperm immobilization. Finally, we discuss future strategies to incorporate advanced polymeric nanocarriers, leveraging insights from pulmonary delivery innovations, to optimize therapeutic potency and mucosal durability for next-generation intravaginal mRNA delivery systems. Overall, these findings establish the intravaginal mRNA-encoded antibody platform as a promising, accessible solution that empowers women with comprehensive control over their reproductive health.

Degree

thesis:*
Name thesis:degree_name
Biomedical Engineering, PhD
Department thesis:degree_department
Biomedical Engineering (Joint GT/Emory Department)
Grantor
Georgia Institute of Technology
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Joo, Jae Yeon
Advisor dc:contributor.advisor
  • Santangelo, Philip J.
Committee members dc:contributor.committeemember
  • Dahlman, James
  • Haynes, Karmella
  • Myers, David
  • Villinger, Francois

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/81729

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Joo, Jae Yeon. Development of Intravaginal mRNA-Encoded Antibodies for HIV Prevention and Non-Hormonal Contraception. Georgia Institute of Technology, 2026. https://hdl.handle.net/1853/81729